M
Mengjie Kong
Researcher at Guangdong Pharmaceutical University
Publications - 5
Citations - 62
Mengjie Kong is an academic researcher from Guangdong Pharmaceutical University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 1, co-authored 1 publications receiving 9 citations.
Papers
More filters
Journal ArticleDOI
Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise.
Mengjie Kong,Kang Xie,Minghui Lv,Jufei Li,Jianyu Yao,Kaixuan Yan,Xiaoqin Wu,Ying Xu,Dewei Ye +8 more
TL;DR: Given that metabolic inflammation has been established as a key pathophysiological event that drives the progression of diabetes, this paper focuses on the protective effects of representative phytochemicals in metabolic inflammation.
Journal ArticleDOI
Eugenol treatment delays the flesh browning of fresh-cut water chestnut (Eleocharis tuberosa) through regulating the metabolisms of phenolics and reactive oxygen species
Lijuan Zhu,Wanfeng Hu,Ayesha Murtaza,Aamir Iqbal,Jiaxing Li,Jiao Zhang,Junjie Li,Mengjie Kong,Xiaoyun Xu,Siyi Pan +9 more
TL;DR: In this article , the potential mechanism behind browning inhibition in fresh-cut water chestnuts (FWC) after eugenol (EUG) treatment was investigated by comparing the difference in browning behavior between surface and inner tissues.
Journal ArticleDOI
Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
Hui-Qing Lin,Lin Wang,Zhuohao Liu,Ke Ren Long,Mengjie Kong,Dewei Ye,Xi Chen,Kai Wang,Kelvin Kl Wu,Mengqi Fan,Erfei Song,Cunchuan Wang,Ruby L. C. Hoo,Xiaoyan Hui,Philip Hallenborg,Hailong Piao,Aimin Xu,Kenneth K.Y. Cheng +17 more
TL;DR: Findings suggest that MDM2 acts as a negative regulator of hepatic ApoB levels and TG‐VLDL secretion in MAFLD, and inhibition of theMDM2‐ApoB interaction may represent a potential therapeutic approach forMAFLD treatment.
Journal ArticleDOI
Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR/miR-34a/SIRT1 regulatory loop.
Mengjie Kong,Yan Peng,Liyan Qiu +2 more
TL;DR: In this article , an oligochitosan-derivated nanoveicle (UBC) with esterase responsive degradability was designed to co-encapsulate FXR agonist (obeticholic acid, OCA) and miR-34a antagomir (anta-miR- 34a) by dialysis method.
Journal ArticleDOI
Browning inhibition in fresh-cut Chinese water chestnut under high pressure CO2 treatment: Regulation of reactive oxygen species and membrane lipid metabolism.
Lijuan Zhu,Wanfeng Hu,Ayesha Murtaza,Aamir Iqbal,Mengjie Kong,Jiao Zhang,Jiaxing Li,Xiaoyun Xu,Siyi Pan +8 more
TL;DR: In this paper , a Chinese water chestnut (CWC) was treated with high pressure CO2 (HPCD) to inhibit the browning reactions, and the underlying mechanism was investigated.